69238-1552Level 3
Memantine and Donepezil Hydrochlorides Extended-release (Memantine and Donepezil)
**Product type:** Human Prescription Drug
**Active ingredient:** DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE
**Strength:** 10; 7 mg/1; mg/1
**Dosage form:** Capsule, Extended Release
**Route:** Oral
**Labeler:** Amneal Pharmaceuticals NY LLC
**Marketing category:** ANDA (ANDA208328)
**Pharmacologic class:** Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA], N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]
GET
/api/v1/systems/ndc_fda/nodes/69238-1552Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.